Skip to content
The Department of Health and Human Services (HHS) and Department of Commerce (DOC) will investigate using Bayh-Dole march-in rights as a way to control […]
HHS investigating using Bayh-Dole march-in rights for price controls Read More »
Following her appearance before the Senate Finance Committee on Thursday, U.S. Trade Representative Ambassador Katherine Tai revisited the administration’s trade policy agenda on Friday
Biotech corn in the spotlight; USTR pledges to use all USMCA tools Read More »
The Senate Commerce Committee approved legislation yesterday which prohibits pharmacy benefit managers (PBMs) from pocketing the rebates they collect from drug makers. The bill
PBM Transparency Act now heads to full Senate Read More »
During a hearing Thursday, March 23, members of the Senate Finance Committee urged U.S. Trade Representative (USTR) Ambassador Katherine Tai to take action regarding
Mexico corn ban and TRIPS waiver dominate discussion in USTR hearing Read More »
Government policy impacting biotech—including drug price controls, pharmacy benefit managers (PBMs), accelerated approval, and support for new antibiotics—received a public airing this week when
People with an aggressive blood cancer that does not respond to treatments have been given new hope for a cure after Syndax Pharmaceuticals’ experimental
Syndax’s experimental drug signals new chance at life for a third of AML patients Read More »
It’s World Water Day, and the U.N. encourages everyone to take action in any way possible. And biotechnology has the potential to make a
It’s World Water Day, and biotech can join in the efforts for cleaner water Read More »
Despite the existence of the bioengineered label on foods for over a year, consumer behavior regarding food choices has remained largely unchanged. Starting January
Consumer habits largely unaffected by foods labeled for bioengineered ingredients Read More »
While awaiting for the public hearing on the proposed expansion of the COVID IP waiver that the U.S. International Trade Commission (USITC) has scheduled
IP waiver directly threatens U.S. medical innovation, biomanufacturing Read More »
Two issues critical for the biotech sector kept busy Capitol Hill on March 16: the collapse of Silicon Valley Bank (SVB) and Mexico’s biotech
SVB collapse and Mexico corn ban consultations keep Capitol Hill busy Read More »
